OBESITYWEEK OPENING KEYNOTE SPEAKER
TUESDAY, NOV 5, 8:00 AM | View Session Information
William T. Cefalu, MD
Chief Scientific, Medical & Mission Officer | President, ADA Research Foundation
Dr. William T. Cefalu is Chief Scientific, Medical & Mission Officer of the American Diabetes Association (ADA), and President of the American Diabetes Association Research Foundation. In his role, Dr. Cefalu leads the ADA’s Mission team, which is focused on efforts to prevent and cure diabetes and to improve the lives of all people affected by diabetes. During his nearly 35-year career as a physician caring for patients, a scientist and a health care expert, Dr. Cefalu has been an active leader within the ADA—as a physician member and most recently serving as the editor-in-chief of Diabetes Care, the highest-ranked, peer-reviewed journal in diabetes, from 2011-2017.
Prior to joining the ADA in February 2017, Dr. Cefalu was the Executive Director, the George A. Bray, Jr. Endowed Super Chair in Nutrition and a professor at Louisiana State University’s (LSU’s) Pennington Biomedical Research Center (Pennington Biomedical) in Baton Rouge, La. Notably, Dr. Cefalu also had research support from the National Institutes of Health (NIH) for more than 25 years and was the principal investigator for two NIH research centers. In addition, Dr. Cefalu is widely published in journals, books and book chapters, including more than 295 manuscripts and 25 book chapters, and served as the editor of five books on the management of diabetes.
ASMBS INTEGRATED HEALTH KEYNOTE SPEAKER
TUESDAY, NOV 5, 1:30 PM | View Session Information
Walter J. Pories, MD, FACS
Professor of Surgery, Biochemistry and Kinesiology at East Carolina University
Dr. Walter Pories, is a Professor of Surgery, Biochemistry and Kinesiology at East Carolina University. He has served as President of the Society for Environmental Health and Geochemistry, the Association of Program Directors in Surgery, the American Society for Metabolic and Bariatric Surgery, as the 2nd Vice President of the American College of Surgeons and Vice President of the Southern Surgical Association, as well as editor-in- chief and associate editor of several journals.
To improve the outcomes from bariatric surgery, he helped found and chaired the Surgical Review Corporation that developed the international Bariatric Surgery Centers of Excellence Program with its BOLD database that led to a reduction of the 90 day mortality in the US from about 10% to 0.3%. He was also the first to develop a postgraduate curriculum for graduate surgical education, published through four editions. His current research interest is the molecular explanation why type 2 diabetes clears within a matter of days following bariatric surgery. His group has had uninterrupted funding from the NIH for over three decades.
ASMBS MASON LECTURER
WEDNESDAY, NOV 6, 10:30 AM | View Session Information
Philip Schauer, MD
Professor of Surgery, Cleveland Clinic Lerner College of Medicine | Director, Cleveland Clinic Bariatric and Metabolic Institute
Dr. Philip Schauer is Professor of Surgery at the Cleveland Clinic Lerner College of Medicine, and Director of the Cleveland Clinic Bariatric and Metabolic Institute (BMI). He is past president of the American Society for Metabolic & Bariatric Surgery (ASMBS). He is former Chair and founder of ObesityWeek (2012-present) and Co-Chair of the Diabetes Surgery Summit (2007, 2015, 2019).
Dr. Schauer’s clinical interests include minimally invasive, foregut and bariatric surgery. He assisted the development of many complex foregut operations including laparoscopic gastric bypass, sleeve gastrectomy, anti-reflux surgery, paraesophageal hernia repair, and minimally invasive esophagectomy. He has performed more than 8000 operations for severe obesity and diabetes. His research interests include the pathophysiology of obesity and type 2 diabetes, and outcomes of minimally invasive and metabolic surgery. He has authored more than 350 scientific papers, 60 textbook chapters, and 3 textbooks related to obesity, bariatric/metabolic surgery and gastrointestinal surgery with more than 20,000 citations.He holds 4 patents for medical devices and is the recipient of the Cleveland Clinic 2015 Sones Award – highest honor for scientific innovation at the Cleveland Clinic. He is the recipient of the SAGES Pioneer in Surgical Endoscopy Award 2018.
TOS KEYNOTE SPEAKER
THURSDAY, NOV 7, 9:45 AM | View Session Information
Barbara E. Corkey, PhD
Why Have We Failed to Decrease Obesity and Diabetes?
Barbara E. Corkey has been the Zoltan Kohn Professor of Medicine and Vice Chair for Research in the Department of Medicine at Boston University. Dr. Corkey has been a leader in the fields of diabetes and obesity research for over 50 years with over 180 related publications and 40 years of continuous government research support. The Corkey laboratory has been engaged in research on obesity and diabetes, with a particular focus on metabolic signal transduction in ß-cells, adipocytes and hepatocytes, intercellular communication via circulating redox and the role of hyperinsulinemia in obesity and diabetes.
She does seminal work on the molecular basis of nutrient signaling that has a major impact on our current understanding of health and disease. Finally, Barbara has received numerous honors including the NIH MERIT Award, National Honorary Membership in Iota Sigma Pi, the National Honor Society of Women in Chemistry, Women in Science Lecturer at the Boston Museum of Science, the George Bray Founders Award of the Obesity Society, the Charles H. Best Lectureship and Award, University of Toronto and the Banting Medal for Scientific Achievement from the American Diabetes Association. A current major focus is on developing clinical/basic collaborative multi-PI grants to explore novel approaches to understand and treat metabolic diseases.